Could some breast cancer patients avoid surgery altogether?
NCT ID NCT04578106
Summary
This study explored whether women with a specific type of early-stage, HER2-positive breast cancer could safely skip surgery and lymph node removal. To qualify, patients first needed to have no detectable cancer left after completing a standard course of targeted drug therapy. The goal was to see if avoiding surgery in these carefully selected patients could maintain good cancer control while improving quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HER2-POSITIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Clinic de Barcelona
Barcelona, Barcelona, 08036, Spain
Conditions
Explore the condition pages connected to this study.